AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function

RecruitingNAAges 18 Years - 75 YearsAllBayer
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The main purpose of this study is to investigate how reliable a test assessing the renal functional reserve (RFR) and the maximum glomerular filtration rate (maxGFR) are. MaxGFR and RFR assessments are repeated twice at 1-month intervals. If precise, this test may improve the measure of kidney function and be useful in future studies for people with chronic kidney problems. To do this, the researchers will collect and analyze information about kidney function from up to 50 adults, including healthy people and people with stable kidney problems. Each person will come to the study center for a screening visit and then three study days, each about a month apart. On each study day, participants will have blood and urine samples taken before and after drinking a protein shake. The tests will measure things like creatinine, cystatin C, and other markers in the blood and urine to see how the k

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Participant must be 18 to 75 years of age inclusive, at the time of signing the ICF. * Stable medical condition defined as no new drug or other treatment prescribed for a chronic condition within 60 days prior to Study Day 1. * Body weight between 50 and 100 kg. * Female Participants: A participant is eligible to participate if not pregnant or breastfeeding. If a urine test cannot be confirmed as negative at screening (e.g., an ambiguous result), the participant must be excluded from participation. Exclusion Criteria: * Recent surgical intervention within 60 days prior to Study Day 1. * New clinical diagnosis established within 60 days prior to Study Day 1. * New drug prescription within 60 days prior to Study Day 1. * Relevant change in severity of any medical condition within 60 days prior to Study Day 1, e.g. disease flare. * Known congenital amino acid metabolism disorders. * Severe hypersensitivity to milk products. * Known liver cirrhosis. * Regular use of non-steroidal anti-inflammatory drugs (NSAIDs). * Impaired kidney function with eGFR \<30 mL/min/1.73m2
๐Ÿ’Š

What it tests

  • No investigational study intervention
๐Ÿ“

Where

1 site
Bayer AG - Occupational Health Services
Berlin, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy